Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs ANUH PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. ANUH PHARMA MARKSANS PHARMA./
ANUH PHARMA
 
P/E (TTM) x 21.5 22.7 94.7% View Chart
P/BV x 3.9 5.1 77.1% View Chart
Dividend Yield % 0.3 0.8 40.5%  

Financials

 MARKSANS PHARMA.   ANUH PHARMA
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
ANUH PHARMA
Mar-23
MARKSANS PHARMA./
ANUH PHARMA
5-Yr Chart
Click to enlarge
High Rs74110 67.7%   
Low Rs3977 50.3%   
Sales per share (Unadj.) Rs40.9105.3 38.8%  
Earnings per share (Unadj.) Rs5.97.2 81.1%  
Cash flow per share (Unadj.) Rs7.09.2 76.4%  
Dividends per share (Unadj.) Rs0.502.00 25.0%  
Avg Dividend yield %0.92.1 41.3%  
Book value per share (Unadj.) Rs38.548.1 80.0%  
Shares outstanding (eoy) m453.1650.11 904.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.40.9 155.9%   
Avg P/E ratio x9.712.9 74.6%  
P/CF ratio (eoy) x8.110.2 79.2%  
Price / Book Value ratio x1.51.9 75.7%  
Dividend payout %8.527.7 30.8%   
Avg Mkt Cap Rs m25,6314,683 547.3%   
No. of employees `000NANA-   
Total wages/salary Rs m2,394172 1,395.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m18,5215,275 351.1%  
Other income Rs m59361 970.0%   
Total revenues Rs m19,1155,336 358.2%   
Gross profit Rs m3,393518 655.0%  
Depreciation Rs m51997 534.6%   
Interest Rs m917 1,223.6%   
Profit before tax Rs m3,377475 711.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m723113 640.6%   
Profit after tax Rs m2,653362 733.3%  
Gross profit margin %18.39.8 186.6%  
Effective tax rate %21.423.8 90.1%   
Net profit margin %14.36.9 208.9%  
BALANCE SHEET DATA
Current assets Rs m16,9973,076 552.5%   
Current liabilities Rs m3,6541,613 226.5%   
Net working cap to sales %72.027.7 259.8%  
Current ratio x4.71.9 244.0%  
Inventory Days Days666 8.7%  
Debtors Days Days821,185 6.9%  
Net fixed assets Rs m5,246966 543.0%   
Share capital Rs m453251 180.9%   
"Free" reserves Rs m16,9982,162 786.4%   
Net worth Rs m17,4522,412 723.5%   
Long term debt Rs m00-   
Total assets Rs m22,2424,042 550.3%  
Interest coverage x38.064.6 58.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.81.3 63.8%   
Return on assets %12.39.1 135.1%  
Return on equity %15.215.0 101.4%  
Return on capital %19.920.0 99.4%  
Exports to sales %052.5 0.0%   
Imports to sales %7.353.2 13.7%   
Exports (fob) Rs mNA2,770 0.0%   
Imports (cif) Rs m1,3482,808 48.0%   
Fx inflow Rs m6,4912,770 234.4%   
Fx outflow Rs m1,3482,808 48.0%   
Net fx Rs m5,143-38 -13,534.3%   
CASH FLOW
From Operations Rs m2,374539 440.5%  
From Investments Rs m-2,592-435 596.1%  
From Financial Activity Rs m1,978-123 -1,610.1%  
Net Cashflow Rs m1,760-19 -9,418.5%  

Share Holding

Indian Promoters % 43.9 69.9 62.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.3 0.0 -  
FIIs % 15.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 56.2 30.1 186.8%  
Shareholders   237,377 20,520 1,156.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs ANUH PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs ANUH PHARMA Share Price Performance

Period MARKSANS PHARMA. ANUH PHARMA S&P BSE HEALTHCARE
1-Day 0.46% -1.48% 1.18%
1-Month -0.72% 17.85% -0.75%
1-Year 109.61% 210.26% 61.82%
3-Year CAGR 45.11% 38.85% 18.16%
5-Year CAGR 43.62% 29.47% 19.79%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the ANUH PHARMA share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of ANUH PHARMA the stake stands at 69.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of ANUH PHARMA.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 8.5%.

ANUH PHARMA paid Rs 2.0, and its dividend payout ratio stood at 27.7%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of ANUH PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.